Preload Image
Preload Image
Report Store mobile icon
Global Immunoglobulins Market Growth 2024-2030

Global Immunoglobulins Market Growth 2024-2030

2024

Global Immunoglobulins Market Growth 2024-2030

Immunoglobulins market size was valued at US$ 10.22 billion in 2024, driven by growing demand in therapeutic applications and immune deficiency treatments.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global immunoglobulins market has witnessed substantial growth due to the increasing prevalence of immune deficiencies, autoimmune disorders, and chronic diseases worldwide. Immunoglobulins, also known as antibodies, are crucial components of the immune system that help defend the body against infections and foreign invaders. These proteins are extracted from human plasma and are used in a variety of therapeutic applications, including the treatment of conditions such as immunodeficiencies, hematological disorders, neurological diseases, and autoimmune disorders. The rising number of patients with conditions like primary immunodeficiency (PID), chronic inflammatory demyelinating polyneuropathy (CIDP), and Guillain-Barré syndrome has created a strong demand for immunoglobulin therapies. Additionally, the growing awareness of immunoglobulin-based treatments and advancements in biotechnology have contributed to the market's expansion. As healthcare systems evolve, governments and healthcare organizations are increasingly investing in the development of immunoglobulin therapies to address unmet medical needs. Furthermore, the increasing number of plasma donation centers and the improvements in the collection and purification processes of immunoglobulins have made these therapies more accessible to patients. The expanding healthcare infrastructure in emerging economies, coupled with the rise in healthcare spending, is expected to further boost the demand for immunoglobulins. These factors, combined with ongoing research and the development of new immunoglobulin formulations, are expected to drive the global immunoglobulins market in the coming years.

According to Publisher, the global Immunoglobulins market size was valued at US$ 10220 million in 2024. With growing demand in downstream market, the Immunoglobulins is forecast to a readjusted size of US$ 13660 million by 2030 with a CAGR of 4.2% during review period. North America dominates the global immunoglobulins market, accounting for a significant share due to the high demand for immunoglobulin therapies in the region. The United States, in particular, is a key contributor to the growth of the market, driven by the rising prevalence of autoimmune and immune deficiency diseases, along with an aging population that requires ongoing treatment. The availability of advanced healthcare infrastructure and well-established healthcare reimbursement policies in the region also support market growth. Additionally, North America has witnessed continuous innovation in immunoglobulin therapies, which has helped to enhance the efficacy and safety profiles of treatments. The growing number of clinical trials and research initiatives focused on immunoglobulin therapies has further propelled the market. Europe is another prominent market for immunoglobulins, with countries like Germany, France, and the United Kingdom leading in the adoption of immunoglobulin-based therapies. The demand for immunoglobulin treatments is particularly high in Western Europe, where the healthcare systems are well-developed and healthcare spending is relatively high. The rising awareness of immunodeficiency disorders and the growing number of patients with autoimmune diseases have significantly contributed to the market's growth in the region. Additionally, Europe has a robust plasma collection network that ensures the steady supply of immunoglobulin products. The Asia-Pacific region is expected to experience rapid growth in the immunoglobulins market, driven by the increasing prevalence of immune disorders and improvements in healthcare infrastructure. Countries such as China, India, and Japan are witnessing a growing demand for immunoglobulin therapies, particularly as awareness about autoimmune diseases and immunodeficiencies increases. The rising adoption of advanced medical technologies, increasing healthcare spending, and the expansion of plasma collection centers are key factors driving market growth in the Asia-Pacific region. The Latin American and Middle Eastern regions are also poised for growth, with emerging economies investing in healthcare infrastructure and awareness campaigns aimed at improving the diagnosis and treatment of immune-related diseases.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The immunoglobulins market can be segmented by type, with the primary categories being intravenous immunoglobulin (IVIG), subcutaneous immunoglobulin (SCIG), and others. Intravenous immunoglobulin (IVIG) is the most widely used form of immunoglobulin therapy, accounting for a large share of the market due to its long-established therapeutic applications. IVIG is typically administered in a hospital or clinic setting, where it is delivered intravenously to patients. This treatment is commonly used for conditions such as primary immunodeficiency, autoimmune diseases, and certain neurological disorders. The IVIG segment benefits from its well-established safety profile, ease of administration, and effectiveness in treating a broad range of immune-related conditions. Subcutaneous immunoglobulin (SCIG) is another important segment in the immunoglobulins market, offering an alternative to IVIG for patients who require long-term immunoglobulin therapy. SCIG is administered subcutaneously, providing patients with the flexibility to manage their treatment at home, thereby reducing the need for frequent hospital visits. This convenience has made SCIG increasingly popular among patients with chronic conditions who require ongoing treatment. SCIG also offers a slower infusion rate, which can be better tolerated by some patients compared to the faster infusion of IVIG. The development of home-based treatment options and the growing number of patients who prefer at-home care are expected to drive the demand for SCIG in the coming years. Other immunoglobulin-based therapies, such as intramuscular immunoglobulin (IMIG), are also used in specific conditions, though their market share is smaller compared to IVIG and SCIG. The ongoing research and development in immunoglobulin therapies are focused on improving the efficacy, safety, and convenience of these treatments, which is expected to support the growth of these segments.

The immunoglobulins market can also be segmented by application, with key therapeutic areas including immunodeficiency diseases, autoimmune diseases, neurological diseases, and others. Immunodeficiency diseases, particularly primary immunodeficiency (PID), are among the largest therapeutic areas for immunoglobulin therapies. IVIG and SCIG are commonly used to treat PID, a group of disorders where the immune system is unable to effectively fight infections. Patients with PID require lifelong immunoglobulin therapy to help prevent infections and improve their quality of life. The increasing recognition of immunodeficiencies, along with advancements in diagnostic techniques, has led to a rise in the number of diagnosed cases, thereby driving demand for immunoglobulin therapies. Autoimmune diseases, such as rheumatoid arthritis, lupus, and vasculitis, represent another significant application area for immunoglobulin treatments. Immunoglobulin therapy is used to modulate the immune response and reduce inflammation in patients with these conditions. The effectiveness of immunoglobulin therapy in treating autoimmune diseases has been well-documented, and ongoing research is focused on expanding its use in other autoimmune disorders. Neurological diseases, such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP), are also major areas of application for immunoglobulins. IVIG is often the first-line treatment for these conditions, as it has been shown to reduce symptoms and improve recovery outcomes. The growing prevalence of neurological disorders and the increasing number of patients requiring immunoglobulin therapy are expected to drive further market expansion. Additionally, immunoglobulin therapy is used in other therapeutic areas, including hematology, dermatology, and infectious diseases, where it has proven benefits in improving patient outcomes. As the number of patients with chronic conditions and complex diseases continues to rise, the demand for immunoglobulin therapies is expected to increase, further driving the growth of the global immunoglobulins market.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Immunoglobulins Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Immunoglobulins by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Immunoglobulins by Country/Region, 2019, 2023 & 2030
  • 2.2 Immunoglobulins Segment by Type
  • 2.2.1 IgG
  • 2.2.2 IgA
  • 2.2.3 IgM
  • 2.2.4 IgE
  • 2.2.5 IgD
  • 2.3 Immunoglobulins Sales by Type
  • 2.3.1 Global Immunoglobulins Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Immunoglobulins Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Immunoglobulins Sale Price by Type (2019-2024)
  • 2.4 Immunoglobulins Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Research
  • 2.5 Immunoglobulins Sales by Application
  • 2.5.1 Global Immunoglobulins Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Immunoglobulins Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Immunoglobulins Sale Price by Application (2019-2024)
  • 3 Global Immunoglobulins by Company
  • 3.1 Global Immunoglobulins Breakdown Data by Company
  • 3.1.1 Global Immunoglobulins Annual Sales by Company (2019-2024)
  • 3.1.2 Global Immunoglobulins Sales Market Share by Company (2019-2024)
  • 3.2 Global Immunoglobulins Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Immunoglobulins Revenue by Company (2019-2024)
  • 3.2.2 Global Immunoglobulins Revenue Market Share by Company (2019-2024)
  • 3.3 Global Immunoglobulins Sale Price by Company
  • 3.4 Key Manufacturers Immunoglobulins Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Immunoglobulins Product Location Distribution
  • 3.4.2 Players Immunoglobulins Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Immunoglobulins by Geographic Region
  • 4.1 World Historic Immunoglobulins Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Immunoglobulins Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Immunoglobulins Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Immunoglobulins Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Immunoglobulins Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Immunoglobulins Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Immunoglobulins Sales Growth
  • 4.4 APAC Immunoglobulins Sales Growth
  • 4.5 Europe Immunoglobulins Sales Growth
  • 4.6 Middle East & Africa Immunoglobulins Sales Growth
  • 5 Americas
  • 5.1 Americas Immunoglobulins Sales by Country
  • 5.1.1 Americas Immunoglobulins Sales by Country (2019-2024)
  • 5.1.2 Americas Immunoglobulins Revenue by Country (2019-2024)
  • 5.2 Americas Immunoglobulins Sales by Type
  • 5.3 Americas Immunoglobulins Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Immunoglobulins Sales by Region
  • 6.1.1 APAC Immunoglobulins Sales by Region (2019-2024)
  • 6.1.2 APAC Immunoglobulins Revenue by Region (2019-2024)
  • 6.2 APAC Immunoglobulins Sales by Type
  • 6.3 APAC Immunoglobulins Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Immunoglobulins by Country
  • 7.1.1 Europe Immunoglobulins Sales by Country (2019-2024)
  • 7.1.2 Europe Immunoglobulins Revenue by Country (2019-2024)
  • 7.2 Europe Immunoglobulins Sales by Type
  • 7.3 Europe Immunoglobulins Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Immunoglobulins by Country
  • 8.1.1 Middle East & Africa Immunoglobulins Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Immunoglobulins Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Immunoglobulins Sales by Type
  • 8.3 Middle East & Africa Immunoglobulins Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Immunoglobulins
  • 10.3 Manufacturing Process Analysis of Immunoglobulins
  • 10.4 Industry Chain Structure of Immunoglobulins
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Immunoglobulins Distributors
  • 11.3 Immunoglobulins Customer
  • 12 World Forecast Review for Immunoglobulins by Geographic Region
  • 12.1 Global Immunoglobulins Market Size Forecast by Region
  • 12.1.1 Global Immunoglobulins Forecast by Region (2025-2030)
  • 12.1.2 Global Immunoglobulins Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Immunoglobulins Forecast by Type
  • 12.7 Global Immunoglobulins Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Hualan Biological Engineering Inc.
  • 13.1.1 Hualan Biological Engineering Inc. Company Information
  • 13.1.2 Hualan Biological Engineering Inc. Immunoglobulins Product Portfolios and Specifications
  • 13.1.3 Hualan Biological Engineering Inc. Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Hualan Biological Engineering Inc. Main Business Overview
  • 13.1.5 Hualan Biological Engineering Inc. Latest Developments
  • 13.2 Omrix Biopharmaceuticals Ltd.
  • 13.2.1 Omrix Biopharmaceuticals Ltd. Company Information
  • 13.2.2 Omrix Biopharmaceuticals Ltd. Immunoglobulins Product Portfolios and Specifications
  • 13.2.3 Omrix Biopharmaceuticals Ltd. Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Omrix Biopharmaceuticals Ltd. Main Business Overview
  • 13.2.5 Omrix Biopharmaceuticals Ltd. Latest Developments
  • 13.3 Behring GmbH
  • 13.3.1 Behring GmbH Company Information
  • 13.3.2 Behring GmbH Immunoglobulins Product Portfolios and Specifications
  • 13.3.3 Behring GmbH Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Behring GmbH Main Business Overview
  • 13.3.5 Behring GmbH Latest Developments
  • 13.4 Shanghai RAAS Blood Products
  • 13.4.1 Shanghai RAAS Blood Products Company Information
  • 13.4.2 Shanghai RAAS Blood Products Immunoglobulins Product Portfolios and Specifications
  • 13.4.3 Shanghai RAAS Blood Products Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Shanghai RAAS Blood Products Main Business Overview
  • 13.4.5 Shanghai RAAS Blood Products Latest Developments
  • 13.5 Option Care Enterprises
  • 13.5.1 Option Care Enterprises Company Information
  • 13.5.2 Option Care Enterprises Immunoglobulins Product Portfolios and Specifications
  • 13.5.3 Option Care Enterprises Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Option Care Enterprises Main Business Overview
  • 13.5.5 Option Care Enterprises Latest Developments
  • 13.6 ADMA Biologics,
  • 13.6.1 ADMA Biologics, Company Information
  • 13.6.2 ADMA Biologics, Immunoglobulins Product Portfolios and Specifications
  • 13.6.3 ADMA Biologics, Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 ADMA Biologics, Main Business Overview
  • 13.6.5 ADMA Biologics, Latest Developments
  • 13.7 BioScrip
  • 13.7.1 BioScrip Company Information
  • 13.7.2 BioScrip Immunoglobulins Product Portfolios and Specifications
  • 13.7.3 BioScrip Immunoglobulins Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 BioScrip Main Business Overview
  • 13.7.5 BioScrip Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Immunoglobulins Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Immunoglobulins Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IgG
Table 4. Major Players of IgA
Table 5. Major Players of IgM
Table 6. Major Players of IgE
Table 7. Major Players of IgD
Table 8. Global Immunoglobulins Sales by Type (2019-2024) & (K Units)
Table 9. Global Immunoglobulins Sales Market Share by Type (2019-2024)
Table 10. Global Immunoglobulins Revenue by Type (2019-2024) & ($ million)
Table 11. Global Immunoglobulins Revenue Market Share by Type (2019-2024)
Table 12. Global Immunoglobulins Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Immunoglobulins Sales by Application (2019-2024) & (K Units)
Table 14. Global Immunoglobulins Sales Market Share by Application (2019-2024)
Table 15. Global Immunoglobulins Revenue by Application (2019-2024)
Table 16. Global Immunoglobulins Revenue Market Share by Application (2019-2024)
Table 17. Global Immunoglobulins Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Immunoglobulins Sales by Company (2019-2024) & (K Units)
Table 19. Global Immunoglobulins Sales Market Share by Company (2019-2024)
Table 20. Global Immunoglobulins Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Immunoglobulins Revenue Market Share by Company (2019-2024)
Table 22. Global Immunoglobulins Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Immunoglobulins Producing Area Distribution and Sales Area
Table 24. Players Immunoglobulins Products Offered
Table 25. Immunoglobulins Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Immunoglobulins Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Immunoglobulins Sales Market Share Geographic Region (2019-2024)
Table 30. Global Immunoglobulins Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Immunoglobulins Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Immunoglobulins Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Immunoglobulins Sales Market Share by Country/Region (2019-2024)
Table 34. Global Immunoglobulins Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Immunoglobulins Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Immunoglobulins Sales by Country (2019-2024) & (K Units)
Table 37. Americas Immunoglobulins Sales Market Share by Country (2019-2024)
Table 38. Americas Immunoglobulins Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Immunoglobulins Revenue Market Share by Country (2019-2024)
Table 40. Americas Immunoglobulins Sales by Type (2019-2024) & (K Units)
Table 41. Americas Immunoglobulins Sales by Application (2019-2024) & (K Units)
Table 42. APAC Immunoglobulins Sales by Region (2019-2024) & (K Units)
Table 43. APAC Immunoglobulins Sales Market Share by Region (2019-2024)
Table 44. APAC Immunoglobulins Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Immunoglobulins Revenue Market Share by Region (2019-2024)
Table 46. APAC Immunoglobulins Sales by Type (2019-2024) & (K Units)
Table 47. APAC Immunoglobulins Sales by Application (2019-2024) & (K Units)
Table 48. Europe Immunoglobulins Sales by Country (2019-2024) & (K Units)
Table 49. Europe Immunoglobulins Sales Market Share by Country (2019-2024)
Table 50. Europe Immunoglobulins Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Immunoglobulins Revenue Market Share by Country (2019-2024)
Table 52. Europe Immunoglobulins Sales by Type (2019-2024) & (K Units)
Table 53. Europe Immunoglobulins Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Immunoglobulins Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Immunoglobulins Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Immunoglobulins Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Immunoglobulins Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Immunoglobulins Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Immunoglobulins Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Immunoglobulins
Table 61. Key Market Challenges & Risks of Immunoglobulins
Table 62. Key Industry Trends of Immunoglobulins
Table 63. Immunoglobulins Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Immunoglobulins Distributors List
Table 66. Immunoglobulins Customer List
Table 67. Global Immunoglobulins Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Immunoglobulins Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Immunoglobulins Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Immunoglobulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Immunoglobulins Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Immunoglobulins Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Immunoglobulins Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Immunoglobulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Immunoglobulins Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Immunoglobulins Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Immunoglobulins Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Immunoglobulins Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Immunoglobulins Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Immunoglobulins Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Hualan Biological Engineering Inc. Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 82. Hualan Biological Engineering Inc. Immunoglobulins Product Portfolios and Specifications
Table 83. Hualan Biological Engineering Inc. Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Hualan Biological Engineering Inc. Main Business
Table 85. Hualan Biological Engineering Inc. Latest Developments
Table 86. Omrix Biopharmaceuticals Ltd. Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 87. Omrix Biopharmaceuticals Ltd. Immunoglobulins Product Portfolios and Specifications
Table 88. Omrix Biopharmaceuticals Ltd. Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Omrix Biopharmaceuticals Ltd. Main Business
Table 90. Omrix Biopharmaceuticals Ltd. Latest Developments
Table 91. Behring GmbH Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 92. Behring GmbH Immunoglobulins Product Portfolios and Specifications
Table 93. Behring GmbH Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Behring GmbH Main Business
Table 95. Behring GmbH Latest Developments
Table 96. Shanghai RAAS Blood Products Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 97. Shanghai RAAS Blood Products Immunoglobulins Product Portfolios and Specifications
Table 98. Shanghai RAAS Blood Products Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Shanghai RAAS Blood Products Main Business
Table 100. Shanghai RAAS Blood Products Latest Developments
Table 101. Option Care Enterprises Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 102. Option Care Enterprises Immunoglobulins Product Portfolios and Specifications
Table 103. Option Care Enterprises Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Option Care Enterprises Main Business
Table 105. Option Care Enterprises Latest Developments
Table 106. ADMA Biologics, Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 107. ADMA Biologics, Immunoglobulins Product Portfolios and Specifications
Table 108. ADMA Biologics, Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ADMA Biologics, Main Business
Table 110. ADMA Biologics, Latest Developments
Table 111. BioScrip Basic Information, Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 112. BioScrip Immunoglobulins Product Portfolios and Specifications
Table 113. BioScrip Immunoglobulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BioScrip Main Business
Table 115. BioScrip Latest Developments
List of


Figure 1. Picture of Immunoglobulins
Figure 2. Immunoglobulins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunoglobulins Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Immunoglobulins Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Immunoglobulins Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of IgG
Figure 10. Product Picture of IgA
Figure 11. Product Picture of IgM
Figure 12. Product Picture of IgE
Figure 13. Product Picture of IgD
Figure 14. Global Immunoglobulins Sales Market Share by Type in 2023
Figure 15. Global Immunoglobulins Revenue Market Share by Type (2019-2024)
Figure 16. Immunoglobulins Consumed in Hospital
Figure 17. Global Immunoglobulins Market: Hospital (2019-2024) & (K Units)
Figure 18. Immunoglobulins Consumed in Research
Figure 19. Global Immunoglobulins Market: Research (2019-2024) & (K Units)
Figure 20. Global Immunoglobulins Sales Market Share by Application (2023)
Figure 21. Global Immunoglobulins Revenue Market Share by Application in 2023
Figure 22. Immunoglobulins Sales Market by Company in 2023 (K Units)
Figure 23. Global Immunoglobulins Sales Market Share by Company in 2023
Figure 24. Immunoglobulins Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Immunoglobulins Revenue Market Share by Company in 2023
Figure 26. Global Immunoglobulins Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Immunoglobulins Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Immunoglobulins Sales 2019-2024 (K Units)
Figure 29. Americas Immunoglobulins Revenue 2019-2024 ($ Millions)
Figure 30. APAC Immunoglobulins Sales 2019-2024 (K Units)
Figure 31. APAC Immunoglobulins Revenue 2019-2024 ($ Millions)
Figure 32. Europe Immunoglobulins Sales 2019-2024 (K Units)
Figure 33. Europe Immunoglobulins Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Immunoglobulins Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Immunoglobulins Revenue 2019-2024 ($ Millions)
Figure 36. Americas Immunoglobulins Sales Market Share by Country in 2023
Figure 37. Americas Immunoglobulins Revenue Market Share by Country in 2023
Figure 38. Americas Immunoglobulins Sales Market Share by Type (2019-2024)
Figure 39. Americas Immunoglobulins Sales Market Share by Application (2019-2024)
Figure 40. United States Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Immunoglobulins Sales Market Share by Region in 2023
Figure 45. APAC Immunoglobulins Revenue Market Share by Regions in 2023
Figure 46. APAC Immunoglobulins Sales Market Share by Type (2019-2024)
Figure 47. APAC Immunoglobulins Sales Market Share by Application (2019-2024)
Figure 48. China Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Immunoglobulins Sales Market Share by Country in 2023
Figure 56. Europe Immunoglobulins Revenue Market Share by Country in 2023
Figure 57. Europe Immunoglobulins Sales Market Share by Type (2019-2024)
Figure 58. Europe Immunoglobulins Sales Market Share by Application (2019-2024)
Figure 59. Germany Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Immunoglobulins Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Immunoglobulins Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Immunoglobulins Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Immunoglobulins Sales Market Share by Application (2019-2024)
Figure 68. Egypt Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Immunoglobulins Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Immunoglobulins in 2023
Figure 74. Manufacturing Process Analysis of Immunoglobulins
Figure 75. Industry Chain Structure of Immunoglobulins
Figure 76. Channels of Distribution
Figure 77. Global Immunoglobulins Sales Market Forecast by Region (2025-2030)
Figure 78. Global Immunoglobulins Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Immunoglobulins Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Immunoglobulins Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Immunoglobulins Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Immunoglobulins Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Immunoglobulins Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.